Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • IMMUNOGEN INC Financial Overview

  • Income Statement: IMGN

      2009 2008 Change ( 2008 - 2009  )
    Net Sales/Revenues 27.99 M 40.25 M -12.26 M -43.81%
    Gross Profit 22.99 M 35.80 M -12.81 M -55.72%
    Net Income Before Extra Items/Preferred Div -31.94 M -32.02 M 83,000.00 -0.26%
    Operating Income -31.82 M -34.11 M 2.30 M -7.22%
  • Cash Flow: IMGN

      2009 2008 Change ( 2008 - 2009  )
    Net Cash Flow - Financing 39.36 M 26.01 M 13.35 M 33.92%
    Net Cash Flow - Investing -12.00 M -15.15 M 3.16 M -26.34%
    Net Cash Flow/Operating Activities -13.33 M -20.15 M 6.82 M -51.11%
  • Balance Sheet: IMGN

      2009 2008 Change ( 2008 - 2009  )
    Total Assets 100.70 M 83.34 M 17.37 M 17.24%
    Total Liabilities 33.85 M 28.04 M 5.81 M 17.16%
    Shareholders Equity 66.86 M 55.30 M 11.56 M 17.29%
  • Key Ratios / Statistics: IMGN

    • Valuation

      Price/Earnings (TTM) -4.71
      Price/Sales (TTM) 4.58
      Price/Book (MRQ) 7.34
      Price/Cash Flow (TTM) -17.77
    • Profitability

      Gross Margin 82.15
      Operating Margin -113.68
      Profit Margin -114.11
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 6.63
      Current Ratio (MRQ) 6.02
      Long Term Debt-to-Equity (MRQ) 0.00
    • Management Effectiveness

      Return on Equity (TTM) -88.88
      Return on Assets (TTM) -34.71
      Return on Investments (TTM) -52.29